FCS Press Releases

Juan Garza, MD joins Florida Cancer Specialists & Research Institute, seeing patients at its Tampa Cancer Center.

Leaders from Florida Cancer Specialists & Research Institute have been recognized for their contributions in the field of oncology as recipients of the 40 Under 40 in Cancer Award.

Florida Cancer Specialists & Research Institute recognizes the urgency in addressing disparities in care among the U.S. veteran oncology patient population, Lucio N. Gordan, MD participates in panel focusing on improving their care.

Florida Cancer Specialists & Research Institute unveils its newly formed Disease Site Committee to revolutionize cancer care.

FCS will have a large presence at the FLASCO 2024 Business Oncology Summit where statewide oncology leaders share the latest developments in oncology care.

FCS case study evaluates the benefits of oncology care based on site of service, comparing community oncology, academic centers and hospitals.

Lucio N. Gordan, MD to serve as a featured panelist at the COA PrecisCa Oncology Fellows & Faculty Forum.

A clinical study co-authored by Ernesto Bustinza-Linares, MD has found that proteome testing leads to targeted treatment for NSCLC.

Lucio N. Gordan, MD discusses novel treatments for multiple myeloma in national broadcast hosted by Darzalex.

Nurses and leaders from Florida Cancer Specialists & Research Institute are featured presenters at the 2024 Oncology Nursing Society Congress.

FCS is pleased to share that its financial performance for the first two months of 2024 has surpassed the statewide practice’s budget.

Clinical research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) will be highlighted at the American Association for Cancer Research 2024 Annual Meeting in San Diego as scientists, clinicians and other health care professionals and stakeholders from all over the world gather to share the latest advances in cancer science and medicine.

Pharmacy leaders from Florida Cancer Specialists & Research Institute share expertise and best practices at the NCODA 2024 Spring Forum.

Pharmacy leaders from Florida Cancer Specialists & Research Institute share expertise and best practices at the NCODA 2024 Spring Forum.

Core Ventures, Florida Cancer Specialists & Research Institute’s MSO, announces the formation of a new real-world evidence and analytics company, Vita Nova Insights(SM).